Salestools LogoSalestools
Salestools AI Agents
Solutions
Resources
Company
Pricing
Salestools Logo

Salestools

The #1 AI Agent for Sales teams and Go To Market teams. Sell more, faster, with less effort.

Product

  • AI Sales Agents
  • Intent Data
  • Technology Data
  • Visitor Tracking
  • Co-Pilot
  • Social Selling

Solutions

  • Customer Service
  • E-commerce
  • SaaS
  • Enterprise
  • Small Business

Resources

  • The Report
  • Documentation
  • API Reference
  • Help Center
  • Blog
  • Case Studies
  • Webinars

Company

  • About
  • Careers
  • Press
  • Contact
  • Partners

Our locations

  • New York, HQ
  • Bucharest, AI Research Lab
  • Zug, Switzerland

Β© 2026 Salestools. All rights reserved.

Data Terms & SecurityPrivacy PolicyTerms of ServiceAcceptable Use
All systems operational
Salestools LogoSalestools
Salestools AI Agents
Solutions
Resources
Company
Pricing
Back to Reports
Fundraising

Oyster HR

Oyster HR Raises $150M in Series D

548 Market Street, San Francisco, CA 94104July 23, 20242 min read
Employees
300+

Oyster HR Raises $150M in Series D


Oyster HR has successfully raised $150M in a Series D at a $1.2B valuation led by Stripes, Emergence Capital, Carya Venture Partners.


Company Overview


Oyster HR is a FinTech company headquartered in 548 Market Street, San Francisco, CA 94104, founded in 2020 with 300+ employees.


Global employment platform


Fundraising Details


  • Amount Raised: $150M
  • Round Type: Series D
  • Valuation: $1.2B
  • Date: 2024-07-23
  • Investors: Stripes, Emergence Capital, Carya Venture Partners

About Oyster HR


Global employment platform The company is positioned in the FinTech sector, serving a growing market with innovative solutions.


Key Information


  • Headquarters: 548 Market Street, San Francisco, CA 94104
  • Founded: 2020
  • Team Size: 300+
  • Industry: FinTech

What This Means


This funding round demonstrates strong investor confidence in Oyster HR's vision and execution. The capital will likely be used to:


  • Scale Operations: Expand the team and operational capacity
  • Product Development: Enhance existing products and develop new features
  • Market Expansion: Enter new markets and strengthen presence in existing ones
  • Technology Investment: Invest in infrastructure and technology capabilities

Industry Context


The FinTech sector continues to attract significant investment as companies innovate to meet evolving market demands. Oyster HR's successful fundraising reflects the strong fundamentals and growth potential in this space.


Valuation Milestone


Reaching a $1.2B valuation marks an important milestone for Oyster HR, positioning the company among notable players in the FinTech industry.


Looking Ahead


With this new capital, Oyster HR is well-positioned to execute on its growth strategy and continue building innovative solutions in the FinTech space. The company's trajectory will be one to watch as it deploys this funding to achieve its next phase of growth.


This fundraising news was reported on 2024-07-23. For more information about Oyster HR, visit their headquarters at 548 Market Street, San Francisco, CA 94104.

Company Info

Headquarters
548 Market Street, San Francisco, CA 94104
Founded
2020
Team Size
300+

Topics

Fundraising(2912)Series D(267)FinTechOyster HR

Share

Related Reports

Fundraising
Tebra

Tebra Raises $250M Growth Financing | Healthcare Practice Management Platform

Healthcare practice management platform Tebra secures $250 million in growth financing led by Hildred Capital for AI-driven automation.

SalesTools Research
SalesTools Research
Jan 12, 2026
0 min readβ€’$250M
Fundraising
Harmattan AI

Harmattan AI Raises $200M Series B | Defense Tech Unicorn at $1.4B Valuation

French defense tech company Harmattan AI secures $200 million Series B led by Dassault Aviation, reaching unicorn status.

SalesTools Research
SalesTools Research
Jan 11, 2026
0 min readβ€’$200M
Fundraising
AirNexis Therapeutics

AirNexis Therapeutics Raises $200M Series A | Novel COPD Treatment

Biotech AirNexis Therapeutics emerges from stealth with $200 million Series A for dual PDE3/4 inhibitor COPD therapy.

SalesTools Research
SalesTools Research
Jan 11, 2026
0 min readβ€’$200M

Turn your sales ideas into reality today

Start your 14-day Pro trial today. No credit card required.

Start building for free